CoronaryAtlas logo
CoronaryAtlas
ASCVD Risk Atlas
← Back to table
C

Elevated LDL cholesterol

Lipids & LipoproteinsLab test / biomarkerriskmodifiable
11
evidence score

Also known as: elevated LDL-C levels

PREVENT status

Not a PREVENT input variable.

Causal support

trial evidence

Score components
lit volume: 3meta-analyses: 0trials: 7.8genetic: 0MR bonus:

References (1)

0 meta-analyses / systematic reviews

Clinical trials (5)

NCTTitleStatusTypeInterventions
NCT06597006Two Part (Double-blind Inclisiran Versus Placebo [Year 1] Followed by Open-label Inclisiran [Year 2]) Randomized Multicenter Study to Evaluate Safety, Tolerability, and Efficacy of Inclisiran in Children (2 to Less Than 12 Years) With Homozygous Familial Hypercholesterolemia and Elevated LDL-cholesterolRECRUITINGINTERVENTIONALInclisiran, Placebo
NCT05614219Can Biochemistry Interpretive Comments on Elevated Cholesterol Levels, Increase Referrals to Lipid Clinics and Detection Rate of Familial Hypercholesterolemia? A Step Wedge Cluster Randomized Controlled Trial.RECRUITINGINTERVENTIONALBiochemistry interpretive comment on elevated LDL-C levels
NCT01959971A Phase 1 Study of the Effects of Subcutaneous Doses of Alirocumab on Lipid and Lipoprotein Metabolism in Adults With Mildly Elevated LDL-CholesterolCOMPLETEDINTERVENTIONALalirocumab, Placebo
NCT01004705Cardiovascular Fixed Dose Combination Pill: A Pharmacodynamic Study of a Fixed Dose Combination of Acetylsalicylic Acid, Simvastatin, and Ramipril in Subjects With Elevated LDL CholesterolTERMINATEDINTERVENTIONALCardiovascular fixed dose combination pill (acetylsalicylic acid, simvastatin and ramipril),, Simvastatin
NCT00529542A Six-week Double Blinded, Randomized Trial of Atorvastatin for the Treatment of PCOS Women With Elevated LDL CholesterolCOMPLETEDINTERVENTIONALLipitor, Placebo

Genetic associations (0)

None linked.